AI predicts atrial fibrillation after stroke of unknown cause
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial uses an artificial intelligence (AI) program to see if it can predict which patients who had a stroke from an unknown cause might develop atrial fibrillation (an irregular heart rhythm). If you have a small heart monitor already implanted, the AI will analyze your ECGs to find early signs of AFib, which could help prevent future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years old or older.
- You have had a stroke from an unknown cause (called ESUS) and have a small heart monitor (ICM) implanted or will get one.
- You had a 12-lead EKG (heart tracing) done within 2 weeks before or after your ICM implant.
- Your heart rhythm is normal (sinus rhythm) when you start the study.
- You have never been diagnosed with atrial fibrillation (AFib) before.
- You agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart ultrasound pictures and heart-rhythm recordings to predict who may develop atrial fibrillation (AF) after a stroke or TIA. If you qualify, your results may help doctors better spot people at higher risk earlier.
This trial tests whether an artificial intelligence-enhanced ECG (called SmartECG) can detect hidden atrial fibrillation better than usual care in people who have symptoms like a racing heart or dizziness. If you qualify, you'll be randomly assigned to get the AI-enhanced test or standard monitoring, and followed to see if AF is found.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This trial tests whether an artificial intelligence (AI) system can help choose the best patients for a procedure called catheter ablation for atrial fibrillation (AF). It may improve which people benefit most while keeping safety in mind.
This trial uses an AI tool to analyze your heart's electrical signals (ECG) to better understand your risk of heart failure and how well your heart recovers after a procedure called catheter ablation for atrial fibrillation. It may help guide your treatment if you have early signs of heart failure.
This study uses AI-powered heart monitoring to detect a type of irregular heartbeat (atrial fibrillation) that may develop after a stroke. Catching this condition early could help prevent future strokes and guide your treatment.
Hear when a new Embolic Stroke of Undetermined Source trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.